How is ceftobiprole used in Canada: the CLEAR study final results
George G Zhanel1, Justin Kosar2, Melanie Baxter1
1Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
Ceftobiprole demonstrates high clinical cure rates and an excellent safety profile when used for severe MRSA infections in Canada. It is effective as directed therapy, often in combination with other antibiotics, for patients who have not responded to prior treatments.
Area of Science:
- Infectious Diseases
- Antimicrobial Therapy
- Pharmacology
Background:
- This study reports on the clinical usage of ceftobiprole in Canadian patients.
- Data is derived from the national CLEAR (Canadian Leadership on Antimicrobial Real-Life Usage) registry.
Purpose of the Study:
- To review the final data on ceftobiprole usage from the CLEAR study.
- To survey existing literature on ceftobiprole for treating infectious diseases up to March 2024.
Main Methods:
- Analysis of final data from the ethics-approved CLEAR study.
- Literature review using PubMed for studies on ceftobiprole in infectious diseases.
Main Results:
- Ceftobiprole is primarily used as directed therapy for severe MRSA infections in Canada.
- It is frequently used in patients with prior antimicrobial treatment failure, often combined with daptomycin and/or vancomycin.
- High microbiological and clinical cure rates, along with an excellent safety profile, are reported for ceftobiprole.
Conclusions:
- Ceftobiprole is a valuable directed therapy for severe MRSA infections in Canada, particularly for treatment failures.
- Combination therapy with daptomycin and/or vancomycin shows high efficacy and a favorable safety profile.
- Ceftobiprole is also used empirically for community-acquired and hospital-acquired bacterial pneumonia.
More Related Videos
07:31A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
Published on: February 13, 2020
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Related Concept Videos
01:11Clinical Trials: Overview
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...